UC study: Severe ischemic strokes rare in total patient population
UC researcher presents findings at European Stroke Organisation Conference
A new University of Cincinnati study provides more insight into how few patients have severe ischemic strokes compared to the total stroke patient population in the region.
Yasmin Aziz, MD. Photo/University of Cincinnati.
UC’s Yasmin Aziz, MD, will present a poster on the team’s findings during the European Stroke Organisation Conference (ESOC) this week in Basel, Switzerland.
Ischemic strokes, the most common form of strokes, are caused by a lack of blood flow and oxygen to specific parts of the brain. When a stroke patient arrives at the hospital, Aziz explained, they undergo a CT scan that can help doctors assess the severity of the damage the stroke has caused using a 10-point scale.
“Low scores indicate bigger strokes, while higher scores indicate smaller ones,” said Aziz, assistant professor in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a neurologist at the UC Gardner Neuroscience Institute. “Much of our early treatment options and long-term prognosis depend on this simple score, as strokes due to blood clots can grow without intervention.”
Aziz said this study asked a simple question: How many patients in the region arrive at the hospital with low scores?
Using data from the ongoing Greater Cincinnati/Northern Kentucky Stroke Study, the team found nearly 90% of all patients who arrive at the hospital within 24 hours of symptom onset have minimal ischemic damage on their CT scans, or scores of 9-10 on the scale.
When narrowing down the data to the most severe type of stroke caused by blood clots in the brain, the team found around 14% of these patients have the most severe damage, or scores of 0-2 on the scale.
Our results show the rarity of these severe strokes in a real-world population, rather than in a strictly controlled clinical trial setting.
Yasmin Aziz, MD
“Patients with low scores due to large strokes require considerable resources from the health care system in order to facilitate their care,” Aziz said. “A lot of research in the last two years has been dedicated to determining if we can treat patients with really low scores. Our results show the rarity of these severe strokes in a real-world population, rather than in a strictly controlled clinical trial setting.”
Aziz said she was not surprised by the results, as the data on the occurrence of patients with low scores lined up with prior estimates.
“Thankfully, the majority of strokes are not due to large vessel occlusion, or due to blood clots in vessels supplying large areas of the brain,” she said.
A recent series of clinical trials has shown benefit to blood clot removal for patients with severe strokes, and the research community is working to adjust to this paradigm shift, Aziz said. The study’s data on how common these strokes occur is part of a larger puzzle to optimize research and patient care for all patients, she said.
This study is one of the first publications to come out of the Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) study, an offshoot of the Cincinnati-area stroke study that adds a neuroimaging component to the data collection and research.
“Our team, comprised of internationally renowned experts in stroke epidemiology, radiology and acute stroke treatment, is extremely excited to utilize APRISE to provide the highest quality research to our field,” Aziz said. “We are deeply thankful to the community for their participation in this research, which will be shared with experts from all around the world at ESOC. Together, we hope to push the boundaries of treatment for stroke patients.”
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Aziz will present “Early Ischemic Change at Late Ischemic Stroke Presentation is Uncommon: A Population-Based Study of the Greater Cincinnati Northern Kentucky Stroke Study” May 15 at ESOC.
Other UC involvement at ESOC includes:
- Joseph Broderick, MD, presenting “Optimal blood pressure control for secondary stroke prevention” May 16.
- Pooja Khatri, MD, presenting “Adjunct thrombolytic therapies preventing reocclusion” May 17.
Featured photo at top of illustration of brain with stroke symptoms. Photo/PeterSchreiber.media/iStock.
Related Stories
Improving treatment for deadly brain tumors
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.
Learning more about how cancer affects stroke risk
October 16, 2023
A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.
UC trial tests tongue exercises to improve swallowing function after stroke
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.